F15.15
Other stimulant abuse with stimulant-induced psychotic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F15.15 refers to a condition where an individual abuses stimulants and develops a stimulant-induced psychotic disorder. This condition occurs when the excessive or inappropriate use of stimulant drugs leads to severe psychological symptoms such as hallucinations, delusions, or paranoia. Stimulants include drugs like amphetamines, methamphetamines, and certain prescription medications used for attention deficit hyperactivity disorder (ADHD). Recognizing and understanding this disorder is vital for appropriate management and treatment.
Causes & Symptoms
Clinical Causes: Repeated use or high doses of stimulant drugs Use of illicit stimulant substances like methamphetamine or cocaine Misuse or overuse of stimulant medications prescribed for conditions such as ADHD or narcolepsy Prolonged periods of stimulant binges without adequate breaks Concurrent mental health disorders that may predispose to substance abuse
Key Symptoms: Hallucinations – seeing or hearing things that are not present Delusions – false beliefs that are strongly maintained despite evidence to the contrary Paranoia – suspiciousness or irrational mistrust of others Agitation or restlessness Rapid speech and hyperactivity Confusion or disorganized thinking Anxiety or panic attacks Insomnia or sleep disturbances Potential physical symptoms like rapid heartbeat, increased blood pressure, or tremors
Diagnostic & Treatment
Diagnosis Path: Diagnosis of stimulant-induced psychotic disorder involves a comprehensive clinical assessment. Healthcare providers consider the patient's history of stimulant use, presenting symptoms, and possible underlying mental health conditions. Diagnostic tools may include questionnaires, physical examinations, and possibly laboratory tests to detect the presence of stimulant substances. The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) criteria support the diagnosis, emphasizing the temporal relationship between stimulant use and psychotic episodes, which typically remit after cessation of the drug.
Treatment Protocols: Management of F15.15 often involves a combination of approaches. The primary focus is to discontinue stimulant use, usually under medical supervision. Supportive care, including counseling and psychiatric support, helps address psychotic symptoms and underlying substance abuse issues. Pharmacological treatments might include antipsychotic medications to control hallucinations or delusions. Additionally, therapy options such as cognitive-behavioral therapy (CBT) can help modify behavior and prevent relapse. Long-term treatment plans often include ongoing mental health support and substance abuse counseling to maintain sobriety and mental stability.
Clinical Advice & FAQs
Billing Guidance
Is F15.15 a billable ICD-10 code?
Yes, F15.15 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.15?
Clinical documentation must specify the nature of Other stimulant abuse with stimulant-induced psychotic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference